ストックスクリーナーアプリを入手
141.02
1.61%
2.24
アフターアワーズ：
141.02
前日終値:
$138.78
開ける：
$140.59
24時間の取引高:
2.25M
Relative Volume:
1.07
時価総額：
$24.40B
収益：
$15.50B
当期純損益:
$1.33B
株価収益率:
19.21
EPS:
7.34
ネットキャッシュフロー:
$2.16B
1週間 パフォーマンス:
+2.16%
1か月 パフォーマンス:
-8.10%
6か月 パフォーマンス:
-29.78%
1年 パフォーマンス:
-37.32%
1日の値動き範囲:
$137.75
$141.67
1週間の範囲:
$134.65
$141.95
52週間の値動き範囲:
$134.65
$252.88
Iqvia Holdings Inc Stock (IQV) Company Profile
IQV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
141.02 | 23.88B | 15.50B | 1.33B | 2.16B | 7.34 |
|
TMO
Thermo Fisher Scientific Inc
|
403.75 | 151.18B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
190.47 | 134.17B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
515.55 | 40.60B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.28 | 31.27B | 6.53B | 1.26B | 1.31B | 4.35 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-25 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-04-10 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-02-03 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-12-20 | 開始されました | Stephens | Overweight |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-09-04 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-07-24 | ダウングレード | Jefferies | Buy → Hold |
| 2024-06-06 | 開始されました | Goldman | Buy |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-02-15 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-02-13 | 開始されました | BTIG Research | Buy |
| 2023-11-02 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-03-17 | 開始されました | Truist | Buy |
| 2022-12-06 | 開始されました | Cowen | Outperform |
| 2022-11-17 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-07-15 | 開始されました | SVB Leerink | Outperform |
| 2022-05-24 | 開始されました | Guggenheim | Buy |
| 2022-04-29 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-04-16 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2020-07-07 | 開始されました | Stephens | Equal-Weight |
| 2020-03-02 | 開始されました | Deutsche Bank | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-12-13 | アップグレード | CFRA | Sell → Hold |
| 2019-11-14 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | アップグレード | Mizuho | Neutral → Buy |
| 2019-05-28 | 開始されました | SVB Leerink | Outperform |
| 2019-01-18 | アップグレード | Jefferies | Hold → Buy |
| 2018-10-09 | 開始されました | UBS | Buy |
| 2018-10-02 | 繰り返されました | Robert W. Baird | Outperform |
| 2018-07-25 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | 繰り返されました | Stifel | Buy |
| 2018-07-03 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | アップグレード | Goldman | Neutral → Buy |
| 2018-03-07 | アップグレード | SunTrust | Hold → Buy |
| 2018-01-19 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Iqvia Holdings Inc (IQV) 最新ニュース
IQVIA Holdings Inc. Announces First Patient Dosed in Renew Phase 2 Trial of Lti-03 in Patients with Ipf - marketscreener.com
IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV S - GuruFocus
Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF - marketscreener.com
IQVIA’s SWOT analysis: healthcare data giant faces industry headwinds - Investing.com Australia
IQVIA’s SWOT analysis: healthcare data giant faces industry headwinds By Investing.com - Investing.com Nigeria
IQVIA Gears Up to Report Q1 Earnings: What's in Store for the Stock? - MSN
IQVIA (IQV) Projects Global Cancer Drug Spending to Hit $441B by 2029 - GuruFocus
(IQV) Trading Advice - news.stocktradersdaily.com
IQV: Cautious Outlook Amidst Delayed Decisions | IQV Stock News - GuruFocus
IQVIA Holdings Inc (IQV) Stock Price Down 3.4% on May 21 - GuruFocus
IQVIA Stock: Is Wall Street Bullish or Bearish? - Barchart.com
IQVIA (IQV) Stock Sees Analyst Target Price Adjustment by JP Mor - GuruFocus
IQVIA (IQV) Stock Sees Analyst Target Price Adjustment by JP Morgan | IQV Stock News - GuruFocus
IQV Q1 Earnings Call: Real-World Evidence Drives Outperformance Amid Sector Uncertainty - Yahoo Finance
IQVIA Holdings (NYSE:IQV) Partners With SCRI Innovations To Enhance Global Oncology Trials - Yahoo
IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials - marketscreener.com
IQVIA Teams Up With SCRI to Expedite Development of New Cancer Therapies - marketscreener.com
IQVIA And SCRI Collaborate To Accelerate Global Oncology Trials - marketscreener.com
Is IQVIA Holdings Inc. (IQV) The Most Undervalued Stock With Smart Money Ratings? - Insider Monkey
Deep Dive Into IQVIA Hldgs Stock: Analyst Perspectives (10 Ratings) - Benzinga
IQVIA Holdings (IQV): Analyst Maintains Rating, Lowers Price Tar - GuruFocus
IQVIA Holdings (IQV): Analyst Maintains Rating, Lowers Price Target | IQV Stock News - GuruFocus
Mizuho Adjusts Price Target for Iqvia (IQV) to $190 | IQV Stock News - GuruFocus
Mizuho Adjusts Price Target on IQVIA Holdings to $190 From $210, Maintains Outperform Rating - marketscreener.com
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Questex’s Fierce Biotech Announces 2025 Fierce CRO Award Finalists - GlobeNewswire Inc.
Positive Outlook for IQVIA Holdings Driven by Resilient TAS, Strategic Capital Allocation, and R&D Strength - TipRanks
IQVIA Holdings Inc. (NYSE:IQV) Q1 2025 Earnings Call Transcript - MSN
IQVIA at BofA Securities 2025: Strong Q1 Amid Market Challenges By Investing.com - Investing.com Nigeria
IQVIA at BofA Securities 2025: Strong Q1 Amid Market Challenges - Investing.com
Investing in IQVIA (IQV)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance
(IQV) Investment Analysis and Advice - news.stocktradersdaily.com
IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates - MSN
IQVIA: Q1 Earnings Support Steady Optimism (NYSE:IQV) - Seeking Alpha
IQVIA raises 2025 revenue guidance amid strong TAS growth and expanded AI deployment - MSN
Morgan Stanley Adjusts Price Target on IQVIA Holdings to $185 From $250, Maintains Overweight Rating - marketscreener.com
Truist Financial Sticks to Its Buy Rating for IQVIA Holdings (IQV) - The Globe and Mail
IQVIA Ups Revenue Forecast After Exceeding Profit Estimates - Finimize
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13 - Business Wire
Barclays Lowers IQVIA Holdings (IQV) Price Target to $165 Amid Demand Concerns | IQV stock price - paginasiete.bo
IQVIA (IQV) Target Price Lowered by UBS, Rating Maintained | IQV Stock News - GuruFocus
IQVIA Holdings (IQV): Barclays Lowers Price Target to $165 | IQV Stock News - GuruFocus
Stephens Adjusts Price Target on IQVIA Holdings to $200 From $250, Maintains Overweight Rating - marketscreener.com
Citigroup Adjusts Price Target on IQVIA Holdings to $160 From $210, Maintains Neutral Rating - marketscreener.com
Baird Adjusts Price Target on IQVIA Holdings to $161 From $195, Maintains Neutral Rating - marketscreener.com
Barclays Adjusts Iqvia (IQV) Price Target Amid Demand Concerns | IQV Stock News - GuruFocus
IQVIA reports first-quarter 2025 results - IQVIA
IQVIA Holdings Inc (IQV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
IQVIA Holdings Inc (IQV) Q1 2025 Earnings Call Highlights: Stron - GuruFocus
Iqvia Holdings Inc (IQV) 財務データ
収益
当期純利益
現金流量
EPS
1.35%
1.96%
大文字化:
|
ボリューム (24 時間):